Aptevo Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
53,337.00
51,115.00
59,317.00
112,415.00
6,973.00
53,689
Depreciation, Depletion & Amortization
666.00
2,021.00
2,907.00
1,900.00
2,300.00
2,390
Other Funds
52,413.00
99,400.00
51,331.00
71,219.00
9,092.00
2,526
Funds from Operations
51,734.00
47,599.00
52,969.00
50,492.00
15,620.00
48,773
Changes in Working Capital
342.00
592.00
4,209.00
14,030.00
4,496.00
3,251
Net Operating Cash Flow
51,392.00
47,007.00
48,760.00
36,462.00
41,573.00
52,024
Capital Expenditures
1,021.00
989.00
1,527.00
2,512.00
1,402.00
Sale of Fixed Assets & Businesses
-
-
-
-
59,763.00
Purchase/Sale of Investments
-
-
-
44,882.00
28,903.00
Net Investing Cash Flow
1,021.00
48,800.00
1,527.00
47,394.00
29,458.00
Issuance/Reduction of Debt, Net
-
-
-
18,038.00
-
Net Financing Cash Flow
52,413.00
99,400.00
51,331.00
89,295.00
9,534.00
Net Change in Cash
-
3,593.00
1,044.00
5,439.00
2,581.00
Free Cash Flow
52,413.00
47,996.00
50,287.00
38,974.00
42,975.00
Deferred Taxes & Investment Tax Credit
-
117.00
1,361.00
15,817.00
2.00
-
Net Assets from Acquisitions
-
47,811.00
-
-
-
Change in Capital Stock
-
-
-
38.00
442.00
Extraordinaries
-
-
-
-
52,697.00
-
About Aptevo Therapeutics
View Profile
